No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Three-dimensional fluorescence lifetime tomography
1.M. A. Franceschini, K. T. Moesta, S. Fantini, G. Gaida, E. Gratton, H. Jess, W. W. Mantulin, M. Seeber, P. M. Schlag, and M. Kaschke, “Frequency-domain techniques enhance optical mammography: Initial clinical results,” Proc. Natl. Acad. Sci. U.S.A. 94, 6468–6473 (1997).
2.S. Fantini, S. A. Walker, M. A. Franceschini, M. Kaschke, P. M. Schlag, and K. T. Moesta, “Assessment of the size, position, and optical properties of breast tumors in vivo by noninvasive optical methods,” Appl. Opt. 37, 1982–1989 (1998).
3.K. T. Moesta, S. Fantini, H. Jess, S. Totkas, M. A. Franceschini, M. Kaschke, and P. M. Schlag, “Contrast features of breast cancer in frequency-domain laser scanning mammography,” J. Biomed. Opt. 3, 129–136 (1998).
4.D. Grosenick, H. Wabnitz, H. H. Rinneberg, K. T. Moesta, and P. M. Schlag, “Development of a time-domain optical mammograph and first in vivo applications,” Appl. Opt. 38, 2927–2943 (1999).
5.S. B. Colak, M. B. van der Mark, G. W. ’t Hooft, J. H. Hoogenraad, E. S. van der Linden, and F. A. Kuijpers, “Clinical optical tomography and NIR spectroscopy for breast cancer detection,” IEEE J. Sel. Top. Quantum Electron. 5, 1143–1158 (1999).
6.B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: Pilot results in the breast,” Radiology 218, 261–266 (2001).
7.H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20, 1334–1340 (2001).
8.E. M. Sevick-Muraca, J. P. Houston, and M. Gurfinkel, “Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents,” Curr. Opin. Chem. Biol. 6, 642–650 (2002).
9.K. Licha, “Contrast agents for optical imaging,” Top. Curr. Chem. 222, 1–29 (2002).
10.C. Bremer, V. Ntziachristos, and R. Weissleder, “Optical-based molecular imaging: Contrast agents and potential medical applications,” Eur. Radiol.13, 231–243 (2003).
11.V. Ntziachristos and R. Weissleder, “Charge-coupled-device based scanner for tomography of fluorescent near-infrared probes in turbid media,” Med. Phys. 29, 803–809 (2002).
12.V. Ntziachristos and R. Weissleder, “Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation,” Opt. Lett. 26, 893–895 (2001).
13.D. J. Hawrysz, M. J. Eppstein, J. Lee, and E. M. Sevick-Muraca, “Error consideration in contrast-enhanced three-dimensional optical tomography,” Opt. Lett. 26, 704–706 (2001).
14.M. J. Eppstein, D. J. Hawrysz, A. Godavarty, and E. M. Sevick-Muraca, “Three-dimensional near-infrared fluorescence tomography with Bayesian methodologies for image reconstruction from sparse and noisy data sets,” Proc. Natl. Acad. Sci. U.S.A. 99, 9619–9624 (2002).
15.J. Lee and E. M. Sevick-Muraca, “3-D Fluorescence enhanced optical tomography using references frequency-domain photon migration measurements at emission and excitation measurements,” J. Opt. Soc. Am. A 19, 759–771 (2002).
16.A. Godavarty, M. J. Eppstein, C. Zhang, S. Theru, A. B. Thompson, M. Gurfinkel, and E. M. Sevick-Muraca, “Fluorescence-enhanced optical imaging in large tissue volumes using a gain modulated ICCD camera,” Phys. Med. Biol. 48, 1701–1720 (2003).
17.A. Godavarty, C. Zhang, M. J. Eppstein, and E. M. Sevick-Muraca, “Fluorescence-enhanced optical imaging of large phantoms using single and simultaneous dual point illumination geometries,” Med. Phys. 31, 183–190 (2004).
18.A. Godavarty, A. B. Thompson, R. Roy, M. J. Eppstein, C. Zhang, and E. M. Sevick-Muraca, “Progress towards diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography,” J. Biomed. Opt. 9, 488–496 (2004).
19.M. J. Eppstein, F. Fedele, J. Laible, C. Zhang, A. Godavarty, and E. M. Sevick-Muraca, “A comparison of exact and approximate adjoint sensitivities in fluorescence tomography,” IEEE Trans. Med. Imaging 22, 1215–1223 (2003).
20.R. H. Mayer, J. S. Reynolds, and E. M. Sevick-Muraca, “Measurement of the fluorescence lifetime in scattering media by frequency-domain photon migration,” Appl. Opt. 38, 4930–4938 (1999).
21.T. L. Troy and E. M. Sevick-Muraca, “Fluorescence lifetime imaging and spectroscopy in random media,” in Applied Fluorescence in Chemistry, Biology, and Medicine, edited by Rettig, Strehmel, Schrader, and Seifert (Springer, Berlin, 1999), pp. 3–39.
22.R. Weissleder, C. H. Tung, U. Mahmood, and A. Bogdanov, “In vivo imaging of tumors with protease-activated near-infrared fluorescent probes,” Nat. Biotechnol. 17, 375–378 (1999).
23.U. Mahmood, C. H. Tung, A. Bogdanov, and R. Weissleder, “Near-infrared optical imaging of protease activity for tumor detection,” Radiology 213, 866–870 (1999).
24.M. Funovics, R. Weissleder, and C. H. Tung, “Protease sensors for bioimaging,” Anal. Bioanal. Chem. 377, 956–963 (2003).
25.J. O. McIntyre, B. Fingleton, K. S. Well, D. W. Piston, C. C. Lynch, S. Gautam, and L. M. Matrisian, “Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity,” Biochem. J. 377, 617–628 (2004).
26.M. A. O’Leary D. A. Boas, X. D. Li, B. Chance, and A. G. Yodh, “Fluorescence lifetime imaging in turbid media,” Opt. Lett. 21, 158–160 (1996).
27.D. Y. Paithankar A. U. Chen, B. W. Pogue, M. S. Patterson, and E. M. Sevick-Murace, “Imaging of fluorescent yield and lifetime from multiply scattered light reemitted from random media,” Appl. Opt. 36, 2260–2272 (1997).
28.M. J. Eppstein, D. E. Dougherty, T. L. Troy, and E. M. Sevick-Muraca, “Biomedical optical tomography using dynamic parameterization and Bayesian conditioning on photon migration measurements,” Appl. Opt. 38, 2138–2150 (1999).
29.R. Roy and E. M. Sevick-Muraca, “A numerical study of gradient-based nonlinear optimization methods for contrast-enhanced optical tomography,” Opt. Express 9, 49–65 (2001).
30.A. B. Milstein, S. Oh, K. J. Webb, C. A. Bouman, Q. Zhang, D. A. Boas, and R. P. Millane, “Fluorescence optical diffusion tomography,” Appl. Opt. 42, 3081–3094 (2003).
31.V. Ntziachristos, C. Bremer, C. H. Tung, and R. Weissleder, “Imaging cathepsin B up-regulation in HT-1080 tumor models using fluorescence-mediated molecular tomography (FMT),” Acad. Radiol. 9, S323–S325 (2002).
32.E. Shives, Y. Xu, and H. Jiang, “Fluorescence lifetime tomography of turbid media based on an oxygen-sensitive dye,” Opt. Express 10, 1557–1562 (2002).
33.Z. Sun, Y. Huang, and E. M. Sevick-Muraca, “Precise analysis of frequency-domain migration measurement for characterization of concentrated colloidal suspensions,” Rev. Sci. Instrum. 73, 383–393 (2002).
34.R. Rajagopalan, P. Uetrecht, J. E. Bugaj, S. A. Achilefu, and R. B. Dorshow, “Stabilization of the optical tracer agent indocyanine green using noncovalent interactions,” Photochem. Photobiol. 71, 347–350 (2000).
35.E. M. Sevick-Muraca and C. L. Burch, “Origin of phosphorescence signals reemitted from tissues,” Opt. Lett. 19, 1928–1930 (1994).
36.M. S. Patterson and B. W. Pogue, “Mathematical model for time-resolved and frequency-domain fluorescence spectroscopy in biological tissues,” Appl. Opt. 33, 1963–1974 (1994).
37.C. L. Hutchinson, J. R. Lakowicz, and E. M. Sevick-Muraca, “Fluorescence life-time based sensing in tissues: A computational study,” Biophys. J. 68, 1574–1582 (1995).
38.F. Fedele, J. P. Laible, and M. J. Eppstein, “Coupled complex adjoint sensitivities for frequency-domain fluorescence tomography: Theory and vectorized implementation,” J. Comput. Phys. 187, 597–619 (2003).
39.J. R. Lakowicz, Principles of Fluorescence Spectroscopy, 2nd ed. (Plenum Publishers New York, 1999).
Article metrics loading...
Full text loading...
Most read this month